2021 Annual Meeting: 113. Hemoglobinopathies, Excluding Thalassemia: Basic and Translational: Emerging Strategies to Identify and Prevent Sickle Cell Disease Pathology

2021 Annual Meeting: 113. Hemoglobinopathies, Excluding Thalassemia: Basic and Translational: Mechanisms Driving Chronic Sickle Cell Disease Complications

2021 Annual Meeting: 114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: Complications in Sickle Cell Disease: Assessment, Prevention

2021 Annual Meeting: 114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: Infections and Inflammation in Sickle Cell Disease: Prevention, Spleen Function

2021 Annual Meeting: 114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: New Therapies for Sickle Cell Disease

2021 Annual Meeting: 201. Granulocytes, Monocytes, and Macrophages: Production and Functions

2021 Annual Meeting: 2021 Annual Meeting: 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Treatment of HIgh Risk and Relapsed/Refractory Myelodysplastic Syndrome

2021 Annual Meeting: 2021 Annual Meeting: 704. Cellular Immunotherapies: Expanding Targets and Cellular Sources for Immunotherapies

2021 Annual Meeting: 203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Regulation of Immune Responses to Infection and Covid-19 Vaccines

2021 Annual Meeting: 301. Vasculature, Endothelial Cells and Platelets: Basic and Translational: Novel Aspects of Platelets in Basic and Translational Science

2021 Annual Meeting: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Thrombopoietin Receptor Agonists and Other Clinical Topics in Thrombocytopenia

2021 Annual Meeting: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Thrombotic Microangiopathies

2021 Annual Meeting: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Treatment of Immune Thrombocytopenia

2021 Annual Meeting: 321. Coagulation and Fibrinolysis: Basic and Translational I

2021 Annual Meeting: 322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Bleeding Phenotypes in Inherited and Acquired Diseases, Interventions, and Complications

2021 Annual Meeting: 322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: New Insights on Hemostatic Challenges in Acquired and Inherited Bleeding Disorders

2021 Annual Meeting: 322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Safety and Efficacy of Non-Factor Therapy in Hemophilia

2021 Annual Meeting: 331. Thrombosis: Thrombosis I

2021 Annual Meeting: 331. Thrombosis: Thrombosis II

2021 Annual Meeting: 332. Anticoagulation and Antithrombotic Therapies

2021 Annual Meeting: 401. Blood Transfusion: Basic and Clinical Studies

2021 Annual Meeting: 501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Development and Aging

2021 Annual Meeting: 501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Inflammation and Stress

2021 Annual Meeting: 503. Clonal Hematopoiesis, Aging and Inflammation: Mechanisms, Disease Associations and the Impact of Aging

2021 Annual Meeting: 506. Hematopoiesis and Stem Cells: Microenvironment

2021 Annual Meeting: 508. Bone Marrow Failure: Basic and Translational Research in Inherited BMF

2021 Annual Meeting: 508. Bone Marrow Failure: Translational and clinical research in acquired BMF

2021 Annual Meeting: 602. Disordered Gene Expression and Epigenetics in Hematologic Malignancies: Basic: Altered epigenetics, regulatory networks and disease progression in hematologic malignancies

2021 Annual Meeting: 602. Disordered Gene Expression and Epigenetics in Hematologic Malignancies: Basic: Cellular and molecular responses in the context of targeted therapies

2021 Annual Meeting: 602. Disordered Gene Expression and Epigenetics in Hematologic Malignancies: Basic: New mechanisms of epigenetic dysregulation in hematologic cancers